诱导澳大利亚狗和猫的吐:药物,副作用和抗药的使用
J Tsitonakis1, E Hall1, A Quain1
1Sydney School of Veterinary Science, University of Sydney, Camperdown, New South Wales, 2006, Australia.
Australian veterinary journal
|May 6, 2025
概括
澳大利亚的兽医通常会用apomorphine治疗狗,用dexmedetomidine/medetomidine治疗猫来诱导吐. 诱导吐在猫身上不那么成功,镇静是一种常见的不良影响. 对猫来说,需要一种更可靠的方法.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 诱导吐是兽医毒理学中毒动物的常见程序.
- 当前的治疗方案各不相同,了解它们的有效性和安全性对于改善患者的治疗结果至关重要.
- 关于澳大利亚兽医使用的特定药物和实践的数据有限.
研究的目的:
- 记录澳大利亚兽医对狗和猫使用的吐剂和方法.
- 为了确定与吐诱导相关的常见不良影响.
- 描述使用抗药物与诱导吐一起使用的情况.
主要方法:
- 一个匿名的在线混合方法调查分发给澳大利亚的兽医.
- 该调查收集了有关使用药物的数据,成功率,不良反应和抗药物管理的数据.
- 数据是在2024年4月至6月期间从317个有效响应中收集的.
主要成果:
- 对狗来说,阿波莫尔芬 (皮下注射) 是最常见的药物 (98.1%),而对猫来说,德克斯梅托米丁/梅托米丁 (肌内注射) 是最常见的药物 (61.7%).
- 与狗 (98.7%) 相比,猫 (57.8%) 的化诱导成功率明显低于狗 (98.7%).
- 镇静是最常见的不良反应;在狗中,亚结合剂阿波莫尔芬增加了不良事件的风险. 经验较少的兽医更有可能在狗身上使用抗药.
结论:
- 结果为澳大利亚的吐诱导实践提供了基准,并突出了相关的不良影响.
- 显然需要更有效和可靠的方法来诱导猫的吐.
- 精炼技术可以改善患者在吐诱导过程中的福利.
更多相关视频
相关概念视频
Prevention of Further Absorption of Poison
1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Pathophysiology of Vomiting
4.6K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
4.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
935
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
935
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
827
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
827
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.2K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K


